Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001641172-25-002775
Filing Date
2025-04-04
Accepted
2025-04-04 16:30:17
Documents
14
Period of Report
2025-03-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 38933
2 ex99-1.htm EX-99.1 13974
  Complete submission text file 0001641172-25-002775.txt   234201

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE hepa-20250304.xsd EX-101.SCH 3027
4 XBRL LABEL FILE hepa-20250304_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE hepa-20250304_pre.xml EX-101.PRE 24173
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 4546
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

EIN.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36856 | Film No.: 25815169
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)